Zobrazeno 41 - 50
of 1 525
pro vyhledávání: '"Kayyali, A."'
Autor:
Mohammad Tahseen Al Bataineh, Axel Künstner, Nihar Ranjan Dash, Rushud Mahmood Abdulsalam, Rafla Zaid Ali Al-Kayyali, M. Besher Adi, Habiba S. Alsafar, Hauke Busch, Saleh Mohamed Ibrahim
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
Alterations in the oral microbiota composition may influence mental health. However, linkages between compositional changes in the oral microbiota and their role in mental health among cigarette smokers remain largely unknown. In this study, we used
Externí odkaz:
https://doaj.org/article/352cc945c7ab40c3be01166a8a4569c1
Autor:
Azizullah Beran, Nameer Aladamat, Mustafa Alchalabi, Mohammed Mhanna, Omar Srour, Yasmin Khader, Ammar Kayyali
Publikováno v:
European Journal of Case Reports in Internal Medicine (2022)
Gradenigo syndrome (GS) was described primarily in the paediatric population, especially in the pre-antibiotic era. GS is rarely reported in the elderly population, especially in the post-antibiotic era. We present the rare case of a 67-year-old man
Externí odkaz:
https://doaj.org/article/b22001a62dc04ca595a37fe405fc4686
Autor:
Hayat Alameen Ali, Osama Muthaffar, Nahla AlKarim, Husam Kayyali, Ahmed Elmardenly, Abdullah Tamim, Hala Alansari
Publikováno v:
Journal of International Medical Research, Vol 50 (2022)
Objective To review the characteristics and outcomes of pediatric patients on a ketogenic diet (KD), an established treatment option for individuals with intractable epilepsy, in a tertiary epilepsy center. Methods This retrospective study included p
Externí odkaz:
https://doaj.org/article/78ff6e737fd6436a87210336d0135506
Autor:
Peletidi, Aliki1,2,3 (AUTHOR) peletidi.a@unic.ac.cy, Kayyali, Reem2 (AUTHOR)
Publikováno v:
Journal of Pharmaceutical Policy & Practice. 11/18/2022, Vol. 15 Issue 1, p1-16. 16p.
Publikováno v:
In Journal of Pharmaceutical Sciences December 2020 109(12):3535-3550
Autor:
Alqadi, Khalid, Alghamdi, Omar, Babtain, Fawzi, Ba'arma, Hanan, Bajammal, Somaya, Albalawi, Miad, Alfadhel, Abdulrahman, Jawhari, Mohammed, Abu-jabber, Amal, Madani, Nadia, Al-Said, Youssef, Baz, Salah, Kayyali, Husam
Publikováno v:
In Epilepsy & Behavior November 2020 112
Publikováno v:
Pharmacy; Feb2024, Vol. 12 Issue 1, p22, 13p
Autor:
Nabhani, Shereen, Harrap, Nicola, Ishtiaq, Sonya, Ling, Victoria, Dudzinski, Maciej, Greenhill, Darrel, Caton, Hope, Philip, Nada, Wells, Joshua, Kayyali, Reem
Publikováno v:
In Currents in Pharmacy Teaching and Learning July 2020 12(7):786-803
Autor:
Aliki Peletidi, Reem Kayyali
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 14, Iss 1 (2021)
Aims The primary aim of the programme was a minimum of a 5% weight reduction of the initial weight, while the secondary outcomes were a reduction in participants’ body mass index (BMI), waist circumference (WC), blood pressure (BP), AUDIT-C score a
Externí odkaz:
https://doaj.org/article/81755f6b0b924b5193eced1eddcba376
Autor:
Mohammad N Kayyali, Oana M Dumitrascu
Publikováno v:
Stroke: Vascular and Interventional Neurology, Vol 1, Iss S1 (2021)
Introduction: Andexanet alfa is the only specific reversal agent for factor Xa inhibitors and received FDA approval in 2018. Here we report an early infusion adverse event in a patient with acute intraventricular hemorrhage (IVH) that received Andexa
Externí odkaz:
https://doaj.org/article/9c8bb1ecee8846628bd7e2f7c0548ca9